CAS: 801312-28-7 - GSK-256066
Fórmula:C27H26N4O5S
InChI:InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)
- Sinónimos:
- 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
- 6-{[3-(Dimethylcarbamoyl)phenyl]sulfonyl}-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK256066 REF: AN-AG00G3OGCAS: 801312-28-7 | 98+% | 171,00 € | Mar 07 May 24 |
 | GSK256066 REF: TM-T6054CAS: 801312-28-7 | 99.66% | 39,00 €~398,00 € | Mar 14 May 24 |
 | 6-(3-(dimethylcarbamoyl)phenylsulfonyl)-4-(3-methoxyphenylamino)-8-methylquinoline-3-carboxamide REF: 3D-FD43369CAS: 801312-28-7 | Min. 95% | A consultar | Mar 18 Jun 24 |
GSK256066
CAS:801312-28-7
GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, …
Fórmula:
C27H26N4O5S
Pureza:
99.66%
Forma y color:
Solid
Peso molecular:
518.58
Ref: TM-T6054
| 1mg | 39,00 € | |
| 2mg | 51,00 € | |
| 5mg | 82,00 € | |
| 10mg | 123,00 € | |
| 25mg | 245,00 € | |
| 50mg | 398,00 € | |
| 1ml*10 (DMSO) | 94,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
6-(3-(dimethylcarbamoyl)phenylsulfonyl)-4-(3-methoxyphenylamino)-8-methylquinoline-3-carboxamide
CAS:801312-28-7
Polymeric matrices are a class of materials that have been optimized to interact with the …
Fórmula:
C27H26N4O5S
Pureza:
Min. 95%
Peso molecular:
518.59 g/mol
Ref: 3D-FD43369
| 1g | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024
